Expression of Ig-like transcript 4 inhibitory receptor in human non-small cell lung cancer

Chest

Volumn 134, Issue 4, 2008, Pages 783-788

  Sun, Yuping ^a   Liu, Jie ^a   Gao, Ping ^a   Wang, Yunshan ^a   Liu, Chuanyong ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Ig like transcript 4; Immunohistochemistry; Infiltrating lymphoid cells; Non small cell lung cancer

Indexed keywords

CELL SURFACE RECEPTOR; IMMUNOGLOBULIN LIKE TRANSCRIPT 4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE; CYTOPLASM; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 54249096540     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-1100     Document Type: Article

References (25)

1. Purtilo DT, Linder J. Oncological consequences of impaired immune surveillance against ubiquitous viruses. J Clin Immunol 1983; 3:197-206
2. Brown JA, Dorfman DM, Ma FR, et al. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol 2003; 170: 1257-1266
3. Dong H, Strome SE, Salomao DR, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 2002; 8:793-800
4. Sun Y, Wang Y, Zhao J, et al. B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer 2006; 53:143-151
5. Manavalan JS, Rossi PC, Vlad G, et al. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl Immunol 2003; 11:245-258
6. Manavalan JS, Kim-Schulze S, Scotto L, et al. Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 2004; 16:1055-1068
7. Hunt JS, Petroff MG, McIntire RH, et al. HLA-G and immune tolerance in pregnancy. Faseb J 2005; 19:681-693
8. Petroff MG, Sedlmayr P, Azzola D, et al. Decidual macrophages are potentially susceptible to inhibition by class Ia and class Ib HLA molecules. J Reprod Immunol 2002; 56:3-17
9. Colonna M, Nakajima H, Cella M. Inhibitory and activating receptors involved in immune surveillance by human NK and myeloid cells. J Leukoc Biol 1999; 66:718-722
10. Colonna M, Samaridis J, Cella M, et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998; 160: 3096-3100
11. Colonna M, Nakajima H, Cella M. A novel family of inhibitory and activating Ig-like receptors for HLA class 2 molecules that modulate function of lymphoid and myeloid cells. J Leukoc Boil 1999; 66:375-381
12. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science 2000; 290:84-89
13. Allan DS, Colonna M, Lanier LL, et al. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med 1999; 189:1149-1156
14. Allan DS, Lepin EJ, Braud VM, et al. Tetrameric complexes of HLA-E, HLA-F, and HLA-G. J Immunol Methods 2002; 268:43-50
15. Allen RL, Raine T, Haude A, et al. Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J Immunol 2001; 167:5543-5547
16. Lepin EJ, Bastin JM, Allan DS, et al. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Eur J Immunol 2000; 30:3552-3561
17. Fleming ID, Phillips JL, Menck HR, et al. The National Cancer Data Base report on recent hospital cancer program process toward complete American Joint Committee on Cancer/TNM staging. Cancer 1997; 80:2305-2310
18. Konishi J, Yamazaki K, Azuma M, et al. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin Cancer Res 2004; 10:5094-6100
19. Young NT, Canavez YF, Uhrberg M, et al. Conserved organization of the ILT/LIR gene family within the polymorphic human leukocyte receptor complex. Immunogenetics 2001; 53:270-278
20. Chang CC, Ciubotariu R, Manavalan JS, et al. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002; 3:237-243
21. Vlad G, Piazza F, Colovai A, et al. Interleukin-10 induces the upregulation of the inhibitory receptor ILT4 in monocytes from HIV positive individuals. Hum Immunol 2003; 64:483-489
22. LeMaoult JK, Zafaranloo C, Le Danff C, et al. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. Faseb J 2005; 19:662-664
23. Hofmeister V, Weiss EH. HLA-G modulates immune responses by diverse receptor interactions. Semin Cancer Biol 2003; 13:317-323
24. Shiroishi M, Tsumoto K, Amano K, et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A 2003; 100:8856-8861
25. Liang S, Horuzsko A. Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G. Hum Immunol 2003; 64:1025-1032